{
  "trial_id": "NCT02848079",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, RAS mutation status, MMR status, prior chemotherapy regimens, presence of measurable disease, absolute neutrophil count (ANC), hemoglobin level, platelet count (PLT), aspartate aminotransferase (AST) level, alanine aminotransferase (ALT) level, total serum bilirubin level, albumin level, serum creatinine level, life expectancy, prior adjuvant chemotherapy, prior radiation therapy, history of allergic reactions, presence of peripheral neuropathy, presence of CNS metastases, presence of other active malignancy, current infection status, prior major surgery, prior anticancer therapy, psychological condition, ability to take oral medication, compliance with study procedures, informed consent status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "ECOG",
          "ECOG performance status"
        ],
        [
          "Histology",
          "MMR status"
        ],
        [
          "KRAS/BRAF mutation",
          "RAS mutation status"
        ],
        [
          "Number of prior therapies",
          "prior chemotherapy regimens"
        ],
        [
          "Progression during prior oxaliplatin",
          "prior anticancer therapy"
        ]
      ],
      "remaining_reference_features": [
        "Location of primary tumor",
        "No.",
        "Stage at diagnosis",
        "High microsatellite instability"
      ],
      "remaining_candidate_features": [
        "presence of measurable disease",
        "absolute neutrophil count (ANC)",
        "hemoglobin level",
        "platelet count (PLT)",
        "aspartate aminotransferase (AST) level",
        "alanine aminotransferase (ALT) level",
        "total serum bilirubin level",
        "albumin level",
        "serum creatinine level",
        "life expectancy",
        "prior adjuvant chemotherapy",
        "prior radiation therapy",
        "history of allergic reactions",
        "presence of peripheral neuropathy",
        "presence of CNS metastases",
        "presence of other active malignancy",
        "current infection status",
        "prior major surgery",
        "psychological condition",
        "ability to take oral medication",
        "compliance with study procedures",
        "informed consent status"
      ]
    },
    "processed-gen-response": "Age, sex, race, ECOG performance status, RAS mutation status, MMR status, prior chemotherapy regimens, presence of measurable disease, absolute neutrophil count (ANC), hemoglobin level, platelet count (PLT), aspartate aminotransferase (AST) level, alanine aminotransferase (ALT) level, total serum bilirubin level, albumin level, serum creatinine level, life expectancy, prior adjuvant chemotherapy, prior radiation therapy, history of allergic reactions, presence of peripheral neuropathy, presence of CNS metastases, presence of other active malignancy, current infection status, prior major surgery, prior anticancer therapy, psychological condition, ability to take oral medication, compliance with study procedures, informed consent status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, ECOG performance status, RAS mutation status, MMR status, Absolute neutrophil count, Hemoglobin, Platelets, Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), Total serum bilirubin, Albumin, Serum creatinine, Prior chemotherapy regimens, Duration of disease,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "ECOG",
          "ECOG performance status"
        ],
        [
          "KRAS/BRAF mutation",
          "RAS mutation status"
        ],
        [
          "Number of prior therapies",
          "Prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Location of primary tumor",
        "No.",
        "Stage at diagnosis",
        "Histology",
        "High microsatellite instability",
        "Progression during prior oxaliplatin"
      ],
      "remaining_candidate_features": [
        "MMR status",
        "Absolute neutrophil count",
        "Hemoglobin",
        "Platelets",
        "Aspartate aminotransferase (AST)",
        "Alanine aminotransferase (ALT)",
        "Total serum bilirubin",
        "Albumin",
        "Serum creatinine",
        "Duration of disease"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, ECOG performance status, RAS mutation status, MMR status, Absolute neutrophil count, Hemoglobin, Platelets, Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), Total serum bilirubin, Albumin, Serum creatinine, Prior chemotherapy regimens, Duration of disease"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, RAS Mutation Status, MMR Status, Prior Chemotherapy Regimens, Prior Radiation Therapy, Presence of Measurable Disease, Baseline Tumor Size, Baseline Hemoglobin, Baseline ANC, Baseline Platelet Count, Baseline AST, Baseline ALT, Baseline Total Bilirubin, Baseline Albumin, Baseline Serum Creatinine.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "ECOG",
          "ECOG Performance Status"
        ],
        [
          "Histology",
          "RAS Mutation Status"
        ],
        [
          "High microsatellite instability",
          "MMR Status"
        ],
        [
          "Number of prior therapies",
          "Prior Chemotherapy Regimens"
        ]
      ],
      "remaining_reference_features": [
        "Location of primary tumor",
        "No.",
        "Stage at diagnosis",
        "KRAS/BRAF mutation",
        "Progression during prior oxaliplatin"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Prior Radiation Therapy",
        "Presence of Measurable Disease",
        "Baseline Tumor Size",
        "Baseline Hemoglobin",
        "Baseline ANC",
        "Baseline Platelet Count",
        "Baseline AST",
        "Baseline ALT",
        "Baseline Total Bilirubin",
        "Baseline Albumin",
        "Baseline Serum Creatinine"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, RAS Mutation Status, MMR Status, Prior Chemotherapy Regimens, Prior Radiation Therapy, Presence of Measurable Disease, Baseline Tumor Size, Baseline Hemoglobin, Baseline ANC, Baseline Platelet Count, Baseline AST, Baseline ALT, Baseline Total Bilirubin, Baseline Albumin, Baseline Serum Creatinine."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, RAS mutation status, MMR status, prior chemotherapy regimens, prior radiation therapy, presence of measurable disease, number of metastatic sites, time since diagnosis of metastatic disease, time since last chemotherapy, ANC, hemoglobin, platelets, AST, ALT, total serum bilirubin, albumin, serum creatinine.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "ECOG",
          "ECOG performance status"
        ],
        [
          "KRAS/BRAF mutation",
          "RAS mutation status"
        ],
        [
          "Number of prior therapies",
          "prior chemotherapy regimens"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Location of primary tumor",
        "No.",
        "Stage at diagnosis",
        "Histology",
        "High microsatellite instability",
        "Progression during prior oxaliplatin"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "MMR status",
        "prior radiation therapy",
        "presence of measurable disease",
        "number of metastatic sites",
        "time since diagnosis of metastatic disease",
        "time since last chemotherapy",
        "ANC",
        "hemoglobin",
        "platelets",
        "AST",
        "ALT",
        "total serum bilirubin",
        "albumin",
        "serum creatinine"
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG performance status, RAS mutation status, MMR status, prior chemotherapy regimens, prior radiation therapy, presence of measurable disease, number of metastatic sites, time since diagnosis of metastatic disease, time since last chemotherapy, ANC, hemoglobin, platelets, AST, ALT, total serum bilirubin, albumin, serum creatinine."
  }
}